LH - NYSE
Labcorp Holdings Inc.
$258.92
+0.47%Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
At a Glance
Live Snapshotlh
Cash at End of Period
Last Annual Value
532.30M
3-Year CAGR
7%
5-Year CAGR
-17%
10-Year CAGR
-3%
Labcorp Holdings Inc. Competitors Analysis of Cash at End of Period
| Company | Cash at End of Period | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Labcorp Holdings Inc. NYSE:LH | 532.30M | -0.3% | -18.4% | 2.1% | |
 Zimmer Biomet Holdings, Inc. NYSE:ZBH | 591.90M | 12.5% | 4.3% | -0.7% | |
 Biogen Inc. NASDAQ:BIIB | 3.01B | 42.0% | 5.9% | 2.6% | |
 Incyte Corporation NASDAQ:INCY | 3.10B | -1.2% | 8.5% | 16.9% | |
 United Therapeutics Corporation NASDAQ:UTHR | 1.56B | 8.8% | 11.7% | 4.3% | |
 STERIS plc NYSE:STE | 439.60M | 28.3% | 14.8% | 5.9% | |
 Quest Diagnostics Incorporated NYSE:DGX | 420.00M | -15.1% | -13.6% | 1.6% | |
 Illumina, Inc. NASDAQ:ILMN | 1.42B | 10.6% | 2.9% | 6.8% | |
791.30M | -2.5% | 0.7% | 14.6% | ||
 DexCom, Inc. NASDAQ:DXCM | 919.10M | 17.4% | -2.7% | 25.5% | |
 Waters Corporation NYSE:WAT | 587.83M | 14.2% | 3.2% | 1.5% |
Labcorp Holdings Inc. Fair Value Envelope
Related Guides
Continue your LH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.